Skip to main content
SI logo

Shoulder Innovations, Inc.

SINYSEHealthcareMedical - Specialties

$19.38Today:- (-)1Y +57.25%

As of Oct 26, 2026 close

Market cap
$401.86M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$10.92$24.60
Volume (live)
-
Avg. volume (3M)
121.09K

Shoulder Innovations (SI) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Shoulder Innovations used $28.61M of cash in operating activities and spent $7.41M on capital expenditures. That left free cash flow of −$36.02M.

Shoulder Innovations Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Shoulder Innovations, Inc. (SI) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023
Period endingDec 2025Dec 2024Dec 2023
Operating Activities
Net Income-40.36-15.62-12.66
Depreciation & Amortization3.212.201.64
Stock Based Compensation1.000.750.45
Change in Working Capital-6.75-1.04-4.77
Change in Accounts Receivable-3.30-0.58-2.69
Change in Inventory-7.64-4.03-2.41
Change in Accounts Payable3.373.12-0.74
Change in Other Working Capital0.820.450.86
Other Operating Activities14.29-0.440.86
Net Cash from Operating Activities-28.61-14.14-13.14
Investing Activities
Capital Expenditures-7.41-4.02-2.75
Purchases of Investments-88.1917.98-29.25
Sales/Maturities of Investments31.3023.263.03
Net Cash from Investing Activities-95.6013.96-28.97
Financing Activities
Debt Repayment0.000.00-5.00
Common Stock Issued65.130.070.00
Other Financing Activities79.370.00-0.15
Net Cash from Financing Activities144.960.0744.73
Summary
Net Change in Cash20.75-0.112.61
Cash at Beginning of Period6.126.243.63
Cash at End of Period26.876.126.24
Free Cash Flow-36.02-18.16-15.89
Supplemental Disclosures
Interest Paid1.691.790.90

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Shoulder Innovations Cash Flow

What is Shoulder Innovations's free cash flow?

Shoulder Innovations had negative free cash flow of $36.02M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$28.61M minus $7.41M of capital expenditures.

How much does Shoulder Innovations spend on capital expenditures?

Shoulder Innovations spent $7.41M on capital expenditures in fiscal 2025, compared with $4.01M a year earlier.

Does Shoulder Innovations pay dividends or buy back shares?

Shoulder Innovations's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition